ConductScience.org, home

Paper32875673

Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development.

Buckton LK and 2 others. Chemistry, 2021. Cited by 139 papers, by iCite.

Cite this record

ConductScience Library. Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development. Papers, record 32875673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32875673

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development.
PubMed
Journal
Chemistry
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
139
iCite
Relative citation ratio, by iCite
9.55
iCite
Revised in PubMed
2021-02-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Buckton LKLaura K
2Rahimi MNMarwa N
3McAlpine SRShelli Rhttps://orcid.org/0000-0003-1058-5252

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Intracellular SpaceMajor topic
Molecular Targeted TherapyMajor topic
Peptides, CyclicMajor topic
Cell Membrane Permeability
Humans

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HBR001Frederick Family FoundationPubMed

Source PubMed

Download CSV of grants

Cited by77

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.

PMIDTitleJournalYearIn PapersSource
42938089Cyclic Peptide PROTACs Restore VHL-Mediated HIF-1α Degradation in Hypoxia.J Am Chem Soc2026https://conductscience.org/library/papers/42938089PubMed
42893140Peptide-Mediated Precise Intracellular Delivery of Bioactive Substances.Int J Nanomedicine2026https://conductscience.org/library/papers/42893140PubMed
42780127Cyclopeptide 161 protects human dermal fibroblasts against UV-induced damage via the MEK1/2-ERK1/2 signaling pathway.Front Physiol2026https://conductscience.org/library/papers/42780127PubMed
42750055Beyond Nature's Blueprint: Macrocyclic Peptides Containing Unnatural Amino Acids in Therapeutic Development.Angew Chem Int Ed Engl2026https://conductscience.org/library/papers/42750055PubMed
42743971HighFold4: extending AlphaFold3 to accurate cyclic peptide conformation prediction via custom chemical connectivity.Brief Bioinform2026https://conductscience.org/library/papers/42743971PubMed
42689447Novel Peptide-Triazole Conjugates: Strategic Synthesis, Antimicrobial Properties, and Molecular Docking Study.J Pept Sci2026https://conductscience.org/library/papers/42689447PubMed
42653761Phage Display as a Promising Platform for Peptide Drug Discovery.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42653761PubMed
42450332Cyclic Peptides as Modulators of Protein-Protein Interactions: A Survival Guide from Discovery Platforms to AI-Driven Design.Int J Mol Sci2026https://conductscience.org/library/papers/42450332PubMed
42446232Hybrid Macrocyclic Peptides - Synthetic Strategies to Diversify and Cyclize Peptide Libraries in Phage Display Selections.Chemistry2026https://conductscience.org/library/papers/42446232PubMed
42441251HFGuidedDesign: de novo design of cyclic peptide binders via structure-guided discrete diffusion.Chem Sci2026https://conductscience.org/library/papers/42441251PubMed
42371970Unified Access to Biaryl-Bridged Linkages Unlocks Structural Diversification of Noncanonical Cyclic Peptides.J Am Chem Soc2026https://conductscience.org/library/papers/42371970PubMed
42225940Generation of membrane-permeable cyclic peptides inhibiting protein-protein interaction.Nat Chem Biol2026https://conductscience.org/library/papers/42225940PubMed
42131907Exploring Passive Permeability Profiles of Cyclic Heptapeptide Chemical Space Uncovers Bioactivity of Mortiamide Scaffold Driven by Colloidal Aggregation.Chembiochem2026https://conductscience.org/library/papers/42131907PubMed
41982931Design of permeability-optimized target-binding macrocycles via direct preference optimization.Chem Sci2026https://conductscience.org/library/papers/41982931PubMed
41958047A Versatile Strategy for Head-to-Tail Macrocyclization and Traceless Backbone Editing of Short Peptides.J Am Chem Soc2026https://conductscience.org/library/papers/41958047PubMed
41787884Macrocyclic Peptides Containing an Imidazopyridinium (IP+) Unit Display Enhanced Passive Cell Permeability.J Am Chem Soc2026https://conductscience.org/library/papers/41787884PubMed
41523155Polyphasic characterization of Biscogniauxia papillata sp. nov. (Graphostromataceae) and isolation of the cytotoxic cyclic pentapeptide cyclobiscognioxin A.Mycol Prog2026https://conductscience.org/library/papers/41523155PubMed
41502766Rational Activity Improvement of Cyclic Peptides through Stabilization and Rigidification of Main Chain Using φ/ψ Plots of Amino Acids.ACS Omega2025https://conductscience.org/library/papers/41502766PubMed
41479885Beyond monoclonal antibodies: constraints and the case for alternative PD-1/PD-L1-targeting formats.Front Immunol2025https://conductscience.org/library/papers/41479885PubMed
41407967An atypical non-ribosomal peptide cyclase catalyzing homochiral coupling with cyclic amine nucleophile.J Antibiot (Tokyo)2026https://conductscience.org/library/papers/41407967PubMed

See all 77 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32875673

GET https://conductscience.org/api/papers/v1/32875673/cited_by?page=2